Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFinseta Regulatory News (FIN)

Share Price Information for Finseta (FIN)

Share Price is delayed by 15 minutes
Get Live Data
8.75    0.00 (0.00%)
Bid:
8.00
Ask:
9.50
Spread: 1.50 (18.75%)
Market Cap: £6.16m
FIN Live PriceLast checked at - London Stock Exchange

Intraday Finseta Share Chart

Stabilisation Notice

15 May 2019 07:00

RNS Number : 0816Z
Finablr PLC
15 May 2019
 

 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE UNLAWFUL.

 

Finablr PLC

Stabilisation Notice

 

 

15 May 2019

 

Finablr PLC hereby gives notice that the entity undertaking stabilisation (the "Stabilising Manager") named below and its affiliates may stabilise the offer of the following securities in accordance with Regulation (EU) No 596/2014 (Market Abuse Regulation) and Commission Delegated Regulation (EU) 2016/1052. Stabilisation transactions aim at supporting the market price of the securities during the stabilisation period. Stabilisation may not necessarily occur and it may cease at any time.

 

The securities:

 

Issuer:

 

Finablr PLC

Shares:

 

Ordinary Shares of £1.00 each (ISIN:GB00BJ7HMW26)

 

Offering size:

 

175,000,000 Ordinary Shares excluding over-allotment option

Description:

Initial Public Offering of Ordinary Shares

 

Offer price:

 

175 pence per Ordinary Share

Stabilisation:

 

Stabilising Manager (and central point within the meaning of Commission Delegated Regulation 2016/1052):

 

J.P. Morgan Securities plc, 25 Bank Street, London, E14 5JP, United Kingdom

 

 

 

Beginning of the stabilisation period:

 

15 May 2019

Stabilisation period to end no later than:

 

14 June 2019

Trading venue where stabilisation may be undertaken:

 

London Stock Exchange

Maximum size and conditions of use of Over-allotment Option:

 

The Stabilising Manager may over-allot the securities to the extent permitted in accordance with applicable law, up to the maximum size of 17,500,000 Ordinary Shares

Over-allotment Option:

 

Terms:

For the purposes of allowing the Stabilising Manager to cover short positions resulting from any over-allotments and/or from sales of Shares effected by them during the stabilisation period, the Stabilising Manager has been granted an Over-allotment Option, pursuant to which the Stabilising Manager may purchase or procure purchasers for additional Shares at the Offer Price. The Over-allotment Option will be exercisable in whole or in part, upon notice by the Stabilising Manager, at any time on or before the 30th calendar day after the commencement of conditional dealings of the Shares on the London Stock Exchange. Any Over-allotment Shares made available pursuant to the Over-allotment Option will be purchased on the same terms and conditions as the Shares being sold in the Offer.

 

Number of shares covered by Over-allotment Option

 

 

17,500,000 Ordinary Shares

Duration:

The Over-allotment Option may be exercised in full or in part at any time during the stabilisation period.

 

Disclaimer

 

In connection with the offer of the above securities, the Stabilising Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time without prior notice. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"), Australia, Canada, Japan or South Africa or any other jurisdiction where such release, publication or distribution would be unlawful. This announcement does not contain or constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or South Africa or any other jurisdiction where such an offer would be unlawful.

The securities of the Issuer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada, Japan or South Africa and, subject to certain exceptions, may not be offered or sold within Australia, Canada, Japan or South Africa or to any national, resident or citizen of Australia, Canada, Japan or South Africa. The release, publication or distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions.

In member states of the European Economic Area (each, a "Relevant Member State"), this announcement and any offer if made subsequently is addressed and directed only at persons who are "qualified investors" within the meaning of the Prospectus Directive ("Qualified Investors"). For these purposes, the expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in a Relevant Member State), and includes any relevant implementing measure in the Relevant Member State and the expression "2010 PD Amending Directive" means Directive 2010/73/EU. In the United Kingdom this announcement is directed exclusively at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), or (ii) who fall within Article 49(2)(A) to (D) of the Order, and (iii) to whom it may otherwise lawfully be communicated, and any investment activity to which it relates will only be engaged in with such persons and it should not be acted upon or relied on by anyone other than such persons.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAUVVVRKVAVARR
Date   Source Headline
4th Jun 20267:00 amRNSFinal Results
23rd Apr 20267:00 amRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSGrant of Options, Director Dealing
17th Apr 202612:10 pmRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSResult of Retail Offer
14th Apr 20267:05 amRNSLaunch of Retail Offer
14th Apr 20267:02 amRNSDirector and PDMR Subscriptions
14th Apr 20267:00 amRNSPlacing, Subscription and Proposed Retail Offer
20th Feb 20267:00 amRNSAppointment of CFO
6th Feb 20262:02 pmRNSExercise of Options, Issue of Equity and TVR
6th Feb 20267:00 amRNSAppointment of Interim CFO
5th Feb 20267:00 amRNSDirectorate change
15th Jan 20267:00 amRNS2025 Full Year Trading Update
13th Nov 20257:00 amRNSVariation of Loan Note Arrangements and TVR
17th Oct 20257:00 amRNSGrant of Options, PDMR Dealing
3rd Oct 20251:57 pmRNSDirector Shareholding
25th Sep 20253:08 pmRNSDirector Shareholdings
19th Sep 202512:55 pmRNSHolding(s) in Company
10th Sep 20257:00 amRNSInterim Results
1st Sep 20257:06 amRNSNotice of Results
14th Aug 20251:07 pmRNSReplacement: Director/PDMR Shareholding
7th Aug 202510:24 amRNSHolding(s) in Company
5th Aug 20257:00 amRNSDirector/PDMR Shareholding
23rd Jul 20252:35 pmRNSHolding(s) in Company
9th Jul 20259:38 amRNSHolding(s) in Company
9th Jul 20257:00 amRNSTrading Update
12th Jun 202511:40 amRNSResult of AGM
28th May 20251:29 pmRNSExercise of Options, Issue of Equity and TVR
24th Apr 202511:44 amRNSDirector/PDMR Shareholding
23rd Apr 20257:00 amRNSFinal Results, Annual Report and Notice of AGM
16th Apr 20257:00 amRNSNotice of Final Results and Investor Presentation
18th Mar 20252:21 pmRNSDirector Share Purchases
11th Mar 20257:00 amRNSReceipt of Licence in Dubai
3rd Mar 20257:00 amRNS-RLaunch of Finseta Corporate Card
15th Jan 20257:00 amRNS2024 Full Year Trading Update
18th Dec 20243:47 pmRNSHolding(s) in Company
25th Oct 20247:00 amRNSGrant of Options, PDMR Dealings
23rd Sep 20241:06 pmRNSDirector/PDMR Shareholding
10th Sep 20247:00 amRNSInterim Results
14th Aug 20247:00 amRNSNotice of Interim Results Presentation
15th Jul 20247:17 amRNSDirector/PDMR Shareholding
9th Jul 20247:00 amRNSH1 2024 Trading Update
20th Jun 202411:40 amRNSResult of AGM
14th Jun 20242:00 pmRNSHolding(s) in Company
7th Jun 20243:49 pmRNSHolding(s) in Company
5th Jun 20247:00 amRNSCompletion of Sale of Capital Currencies
20th May 20247:00 amRNSChange of Name Effective
14th Mar 20222:54 pmRNSAdministrators appointed over Finablr PLC
3rd Mar 20227:30 amRNSStatement re Notification of Auditor Resignation
15th Feb 20227:30 amRNSStatement re Xpress Money Services Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.